Obiettivo dello studio: Better define the pro-inflammatory microenvironment inside ECD lesions. To evaluate the possibility to interfere with the progression of ECD by means of specific inhibitors already available for human usage, in order to find new therapeutic options for the disease.
Responsabile del progetto: Lorenzo Dagna, M.D., San Raffaele Scientific Institute, Milano, ITALY
Informazioni di contatto: Phone: +39-02-26434683 email: orenzo.dagna@unisr.it
Coinvolgimento richiesto del paziente: Al momento non se ne conoscono.

